APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting ba
APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting backbone - SEC filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.